What to ask for on an Iron Blood Test
Ferritin is the biomarker a doctor looks at first, and on its own it can be read the wrong way. These are the other markers on the panel, what each one is for, and the questions worth bringing to an appointment.
The short answer
Ask for ”iron studies” rather than just an iron test. That one phrase gets you ferritin plus transferrin saturation on the same draw, and they give you a more complete reading.
Ask for a CRP on the same test. Ferritin rises with inflammation, so the CRP is what tells you whether the ferritin can be trusted. In one large overseas primary-care study, about half of ferritin tests were ordered without CRP.
Get the actual numbers, not just the word “normal”, and keep them with the name of the lab. When rechecking your biomarkers, try to use the same lab.
- 1Ask for iron studies, not “an iron test”. That panel carries ferritin and transferrin saturation biomarkers together, and they check each other.
- 2Add CRP to the same form. It decides whether the ferritin means what it says.
- 3Ask for the actual numbers and note which lab ran them.
- iA single result is a snapshot. Ferritin moves on its own between tests, so compare like with like and recheck at the same lab.
That list fits in a phone note, and every line of it is ordinary to request. The rest of this article explains what each number does, and gives you the exact questions for the appointment. All of this comes from research papers, which are cited, reinforcing why we have landed on these markers.
01 · BloodsWhat to ask for
An iron panel is not a single marker. Five biomarkers are needed to really tell what’s going on in your body, and two of them have to be asked for separately.
SomadaWhat to ask for on an Iron Blood Test
| The biomarkers | The question it answers | Worth knowing |
|---|---|---|
| Ferritin | How much iron is in storage? | The headline number. Inflammation pushes it up, so it can look comfortable while stores are low. |
| CRP | Is inflammation present? | This is the trust check for ferritin, and usually a separate request. |
| Transferrin saturation | How much iron is circulating and usable right now? | The share of your iron-carrying capacity actually loaded with iron. Less than 20%, and it matters whatever the ferritin number says. |
| Soluble transferrin receptor | How loudly are your cells asking for iron? | Another separate request, much less affected by inflammation than ferritin. When ferritin looks fine but CRP is raised, this is what tells you whether your iron-stores really are fine. |
| Haemoglobin | Has red blood cell production been affected yet? | On the full blood count, not the iron panel. The last number to fall, so normal here is not an all clear. |
Camaschella 2015, New England Journal of Medicine, for the order in which the markers move; Dignass et al. 2018 for the transferrin-saturation threshold; and the RCPA iron studies reporting protocol.
Ferritin is the savings account. Transferrin saturation is what is actually in your purse this week. Haemoglobin is whether the bills start bouncing, and that is the last thing to happen. That order is the single most useful thing to know about iron testing: a normal blood count does not settle the question.
02 · What to add“CRP” tells you whether to believe the ferritin
Ferritin has a weakness. Inflammation raises it. A cold you are getting over, an ongoing flare up, a body carrying general inflammation: all of these push ferritin up without adding any iron into storage. Inflammation also holds iron back from the cells that need it. So ferritin can read high while the iron actually reaching your cells runs short.
Ferritin on its own can read comfortable when the stores behind it are not. The fix costs almost nothing: a CRP, a routine inflammation marker, taken from the same draw. Around half of ferritin tests are ordered without one, in a Swiss study of 255,351 primary-care patients.2Jäger et al. 2024. Swiss primary care, n=255,351. Only 49.6% of ferritin tests had a concomitant CRP. Ferritin testing was more common in women than men at every age band.
Read together, they sort into three simple situations:
- 1Ferritin ▼low, CRP normal. The result means what it says.
- 2Ferritin fine, CRP normal. The result means what it says.
- 3Ferritin fine, CRP ▲raised. The ferritin may be sitting higher than the iron behind it. This is when the other markers earn their place.
There is a fourth combination, low ferritin with a raised CRP. Inflammation can only push ferritin up, so when ferritin still comes back low while inflammation is present, the low reading cannot be blamed on the inflammation, and the stores really are low. The CRP then adds a second question: what is causing the inflammation? That one is for a doctor.
03 · The appointmentSix questions worth asking
The next time you see your GP about your iron, these are the questions worth asking. Always ask to have your results emailed to you, so you have a record.
What was the actual number?
“It’s normal” and “it’s 31” are different pieces of information. The second can be tracked over time. The first cannot.
Which lower limit does this lab use?
Australian labs do not all use the same one. The Royal College of Pathologists recommends 30 µg/L for adults; some labs report against a lower figure.
Was a CRP done at the same time?
Without it, a comfortable ferritin cannot be separated from one raised by inflammation. The single most useful thing to add.
What was my transferrin saturation?
Usually already on the iron studies panel. It is the percentage of your body’s total iron-carrying capacity that is actually carrying iron, and under 20% means not enough iron is reaching the cells that make red blood cells, whatever ferritin says.
If ferritin and CRP are both up, can we look further?
Soluble transferrin receptor or transferrin saturation can answer what ferritin cannot in that situation.
Can we recheck at the same laboratory?
It removes the between-lab spread and makes a small change readable.
04 · Worth asking earlySituations that deserve the test without waiting
A few situations drain iron steadily enough that the conversation is worth starting yourself.
1. Heavy periods. The guidelines here are genuinely patchy. In an international review of 22 clinical guidelines on heavy menstrual bleeding, 11 gave no recommendation on checking iron at all and 4 advised against it.10Mansour et al. 2021. 22 guidelines reviewed. 16 recommend anaemia screening, but 11 give no recommendation on measuring iron or ferritin and 4 explicitly advise against it. One author is Vifor Pharma-affiliated. In one European survey, 46% of women with heavy-bleeding symptoms had never raised them with a doctor.11Fraser et al. 2015. n=4,506 European women. 27.2% reported two or more heavy-bleeding symptoms; 46.0% of those had never consulted a physician. Two authors were Vifor Pharma employees.
2. Heavy periods plus a meat-light diet. Either one alone roughly triples the odds of low iron. Together, in a Swedish study of teenagers, the odds ran over 13 times higher than in those with neither.12Söderman et al. 2025. n=394 post-menarchal students. Heavy menstrual bleeding alone OR 3.0 (2.0–4.6); meat-restricted diet alone OR 3.5 (2.2–5.6); both together OR 13.5 (6.4–28.7). A teenage population, students aged 15 and over. The interaction between the two exposures is what transfers to adult women; the absolute rates do not.
3. Pregnancy. Australian guidelines set out a full round of antenatal checks for anaemia, the late stage where haemoglobin itself has dropped. One regional NSW audit reviewed 150 women who gave birth at the same hospital over four months; of the 103 with screening records available, only 5.3% had completed that full round.13Ebrahim et al. 2024. Retrospective audit, regional NSW, n=150 births over four months. Of the 103 with screening data available, only 5.3% completed the full antenatal screening recommended by the Australian Red Cross Guidelines; 97.1% were iron deficient and 17% anaemic.
One hospital, four months, 150 women. The 5.3% is drawn from the 103 of them whose screening records were available, so it is a snapshot of one place, not a national figure.
4. Regular blood donation. A whole blood donation takes about 470 mL, and what gets checked before you give is haemoglobin, which is the last thing to fall. So a donor can keep passing the test at the door, donation after donation, while her iron stores are drawn steadily down.3Meulenbeld et al. 2024, FIND’EM. 412,888 donors. Ferritin-guided intervals cut iron deficiency in premenopausal women (OR 0.49, 0.37–0.64) while haemoglobin-based DEFERRAL in the same group did not change significantly (OR 0.81, 0.54–1.20, p=0.29). That 0.81 is a deferral rate measured under the SAME ferritin policy, not a separate haemoglobin-managed arm; the trial never ran that comparison. 4Kiss et al. 2013, RISE. n=1,659 donors. Venous haemoglobin had high specificity but poor sensitivity for absent iron stores and for iron-deficient erythropoiesis.
If you want to stay up to date with more studies like this, sign up to Somada Studies.
Now, for the brains.
If you are interested in the evidence and the working behind the above, keep reading. What follows sets out the studies these answers rest on, the numbers that came out of them, and the places where the evidence is thin.
05 · The evidenceWhy a normal blood count settles nothing
Iron runs down in stages.1Camaschella 2015, NEJM. The canonical staging: store depletion, then iron-restricted erythropoiesis, then anaemia. Its own diagnostic table puts transferrin saturation at 16% or above in health and below 16% in iron-deficiency anaemia; the 20% threshold this article uses comes from Dignass 2018, not from here. Soluble transferrin receptor separates absolute deficiency from sequestration because inflammation moves it far less than it moves ferritin. Storage empties first, then red blood cell production starts running short. Anaemia comes last, once there is not enough haemoglobin to carry oxygen around the body properly, and by then most of the buffer is gone. Haemoglobin, the biomarker on a standard blood count, is therefore the last marker in the chain to move.
The cleanest demonstration comes from blood banks, because donors are healthy people losing iron on a schedule. In a trial across 412,888 Dutch donors, managing donation intervals by ferritin roughly halved the odds of iron deficiency in premenopausal women (OR 0.49). Over the same period, how often those women were turned away for low haemoglobin barely shifted (OR 0.81, p=0.29). Stores improved without the screening test that guards the door registering it.3Meulenbeld et al. 2024, FIND’EM. 412,888 donors. Ferritin-guided intervals cut iron deficiency in premenopausal women (OR 0.49, 0.37–0.64) while haemoglobin-based DEFERRAL in the same group did not change significantly (OR 0.81, 0.54–1.20, p=0.29). That 0.81 is a deferral rate measured under the SAME ferritin policy, not a separate haemoglobin-managed arm; the trial never ran that comparison. A separate donor study put it directly: venous haemoglobin has high specificity but poor sensitivity for absent iron stores.4Kiss et al. 2013, RISE. n=1,659 donors. Venous haemoglobin had high specificity but poor sensitivity for absent iron stores and for iron-deficient erythropoiesis. In plain terms, when haemoglobin does flag someone the flag is usually right, but it stays silent on most of the people whose stores are already empty.
A normal blood count is not an all clear for iron.
By the time haemoglobin drops, stores have usually been low for some time. That is not a flaw in the test. It is the order the body spends its reserves in.
06 · The evidenceThe two markers inflammation cannot reach
Transferrin saturation is the share of your iron transport capacity actually carrying iron. Iron runs down in a set order, and saturation falls before haemoglobin does.1Camaschella 2015, NEJM. The canonical staging: store depletion, then iron-restricted erythropoiesis, then anaemia. Its own diagnostic table puts transferrin saturation at 16% or above in health and below 16% in iron-deficiency anaemia; the 20% threshold this article uses comes from Dignass 2018, not from here. Soluble transferrin receptor separates absolute deficiency from sequestration because inflammation moves it far less than it moves ferritin. A value below 20% is the threshold widely used to indicate iron-restricted red blood cell production, independently of where ferritin sits.8Dignass et al. 2018. In heart failure, chronic kidney disease and inflammatory bowel disease, practice uses ferritin below 100 µg/L or transferrin-saturation confirmation rather than the standard cut-off.
Soluble transferrin receptor rises when cells are short of iron, and inflammation does far less to it than it does to ferritin.1Camaschella 2015, NEJM. The canonical staging: store depletion, then iron-restricted erythropoiesis, then anaemia. Its own diagnostic table puts transferrin saturation at 16% or above in health and below 16% in iron-deficiency anaemia; the 20% threshold this article uses comes from Dignass 2018, not from here. Soluble transferrin receptor separates absolute deficiency from sequestration because inflammation moves it far less than it moves ferritin. Not nothing, though: across large population surveys, raised results were more common in women with higher inflammatory markers, and the authors recommend adjusting for it.15Rohner et al. 2017, BRINDA. 11,173 women of reproductive age across 7 surveys. Raised soluble transferrin receptor became more common as inflammatory markers rose, and adjusting for inflammation moved the estimated prevalence of iron-deficient erythropoiesis by 0.3 to 9.5 percentage points. Surveys were largely in low-resource, malaria-endemic settings, so the size does not transfer directly to Australia; the direction does. Read alongside ferritin, it separates a true shortage from iron that is present in the system, but locked away by an inflammatory process. That is the third situation from the CRP list, answered.
This is not a fringe idea, and it runs counter to instinct. In heart failure, kidney disease and inflammatory bowel disease, clinical practice has already set the standard ferritin cut-off aside, using a threshold of 100 µg/L or transferrin-saturation confirmation instead, precisely because ferritin misleads in inflamed environments. The higher line is deliberate: where inflammation is expected, a ferritin reading has to clear a much higher bar before it counts as reassuring.8Dignass et al. 2018. In heart failure, chronic kidney disease and inflammatory bowel disease, practice uses ferritin below 100 µg/L or transferrin-saturation confirmation rather than the standard cut-off.
07 · The evidenceThe fast test, and the shortcuts that do not hold
Most modern analysers can report reticulocyte haemoglobin (written RET-He or CHr): how much haemoglobin went into your newest red blood cells. It returns within hours on the same sample.
It is not accurate enough to stand alone. In 556 patients, the best cut-off gave 68.2% sensitivity and 69.7% specificity.5Auerbach et al. 2021. n=556 consecutive patients. RET-He cut-off 30.7 pg, area under the curve 0.733 (95% CI 0.692–0.775), sensitivity 68.2%, specificity 69.7%. The authors note the design is uncontrolled, single-site and retrospective. A 2026 review of 13 studies in 5,853 donors concluded it cannot replace ferritin.6Yanyiam et al. 2026. 13 studies, 5,853 donors. Concludes reticulocyte haemoglobin cannot replace ferritin; certainty of evidence very low to low. It is also not a way around inflammation: reticulocyte haemoglobin falls when inflammation restricts the iron reaching the marrow, the same way it falls in plain deficiency.14Auerbach & Adamson 2016. Reticulocyte haemoglobin (CHr) is low in iron deficiency, but also in any condition restricting iron availability for haemoglobin synthesis, including inflammation.
The same caution applies to the red-cell measurements on a standard blood count, the ones describing the size of your red blood cells. In a United States national survey of women aged 18 to 49, the four calculations most often used this way flagged nearly everyone who was deficient, but flagged a great many who were not: 40.8% of the women with small red blood cells were not iron deficient at all.7Hou et al. 2026. NHANES, n=3,991 women 18–49, 507 with microcytosis. 40.8% (95% CI 35.5–46.2) were not iron deficient at ferritin <15 µg/L. The four discrimination indices gave sensitivity 92.9–97.6% but specificity 6.7–35.3%.
A second opinion, not a verdict.
Reticulocyte haemoglobin is fast, which makes it useful beside ferritin. It is not a way around inflammation, and nothing on the standard blood count substitutes for ferritin.
08 · The evidenceWhy the number moves between tests
Two findings explain the same-lab rule from the checklist.
Ferritin is not harmonised between Australian laboratories. The Royal College of Pathologists measured one pooled serum sample across 11 assay-instrument setups and received results from 20 to 37 µg/L. The same sample, the same biomarker, 11 different answers. The same college recommends 30 µg/L as the lower limit, and that range falls either side of it. On some of those machines the sample reads low, on others it reads fine.
And within one person, ferritin fluctuates on its own between draws. How much is genuinely unsettled. One set of repeat draws over 28 days put the change needed at about a fifth.9Cokluk et al. 2021. n=21, five draws over 28 days. Reference change value 18.3% at 95% confidence and 24.1% at 99%. A much larger United States national survey, which re-drew 853 people about three weeks apart, found ferritin varied within the same person by nearly 29% in women, the widest gap between men and women of all 34 markers it measured. The estimates do not agree. What the disagreement does settle is the direction of the advice: a small movement between two tests is not, on its own, evidence that anything has changed.
The lower figure comes from 21 people drawn five times over 28 days, and its own authors note that ferritin was handled differently from the rest of their dataset. Read the size as unsettled. That ferritin moves on its own is not in dispute.
So a small drift between two results has probably said nothing, and if the two tests ran at different laboratories it has said even less. Maintain the same lab where you can.
Which markers are in an “iron studies” panel?
Usually serum iron, transferrin or total iron binding capacity, transferrin saturation, and ferritin. A full blood count is commonly ordered alongside it.
CRP and soluble transferrin receptor are generally separate requests, which is why they are worth naming.
What if ferritin is in range but CRP is raised?
That is the situation the additional biomarkers exist for. Inflammation lifts ferritin without adding to stores, so the number may be sitting above what is actually there. Transferrin saturation and soluble transferrin receptor are not affected the same way.
Is a normal haemoglobin enough on its own?
No. Haemoglobin is the last marker to move, because the body keeps red blood cell production going until stores are nearly gone. In donor studies it has poor sensitivity for empty iron stores, meaning it misses most of the people whose stores have already run down. A normal blood count does not settle the question.
Why is my result different from last time?
Some of it is real and some is not. Ferritin moves on its own between draws, and estimates of how much disagree widely. Australian laboratories are also not standardised against each other. A repeat at the same lab is the cleaner comparison.
09 · Bringing it togetherOne number, read in context
Ferritin is worth ordering and worth taking seriously. On its own it answers just one question out of several, and it answers it less clearly when there is inflammation.
A CRP tells you whether to trust it. Transferrin saturation shows what is actually circulating. Soluble transferrin receptor reports what the cells think, and inflammation moves it far less than it moves ferritin. Haemoglobin only moves once something has already been affected, which makes it the last thing to find out.
Ask for the numbers, ask which line the lab uses, and ask what was measured beside it.
References
- Camaschella C. Iron-deficiency anemia. N Engl J Med. 2015;372(19):1832–1843. DOI: 10.1056/NEJMra1401038. pubmed.ncbi.nlm.nih.gov/25946282
- Jäger L, Rachamin Y, Senn O, Burgstaller JM, Rosemann T, Markun S. Ferritin cutoffs and diagnosis of iron deficiency in primary care. JAMA Netw Open. 2024;7(8):e2425692. DOI: 10.1001/jamanetworkopen.2024.25692. pubmed.ncbi.nlm.nih.gov/39102268
- Meulenbeld A, Ramondt S, Sweegers MG, et al. Effectiveness of ferritin-guided donation intervals in whole-blood donors in the Netherlands (FIND’EM): a stepped-wedge cluster-randomised trial. Lancet. 2024;404(10447):31–43. DOI: 10.1016/S0140-6736(24)01085-7. pubmed.ncbi.nlm.nih.gov/38880108
- Kiss JE, Steele WR, Wright DJ, Mast AE, Carey PM, Murphy EL, Gottschall JL, Simon TL, Cable RG. Laboratory variables for assessing iron deficiency in REDS-II Iron Status Evaluation (RISE) blood donors. Transfusion. 2013;53(11):2766-2775. DOI: 10.1111/trf.12209. pubmed.ncbi.nlm.nih.gov/23617531
- Auerbach M, Staffa SJ, Brugnara C. Using reticulocyte hemoglobin equivalent as a marker for iron deficiency and responsiveness to iron therapy. Mayo Clin Proc. 2021;96(6):1510–1519. DOI: 10.1016/j.mayocp.2020.10.042. pubmed.ncbi.nlm.nih.gov/33952394
- Yanyiam P, Jaruthamsophon K, Kusolthammarat K. Diagnostic accuracy of reticulocyte haemoglobin content in detecting iron deficiency without anaemia in blood donors: a systematic review and meta-analysis. Vox Sang. 2026. DOI: 10.1111/vox.70321. pubmed.ncbi.nlm.nih.gov/42437696
- Hou J, Shang X, Zhang H, Fan D. Diagnostic utility of complete blood count indices in ferritin-defined microcytosis among United States women aged 18–49 years. Int J Lab Hematol. 2026. DOI: 10.1111/ijlh.70219. pubmed.ncbi.nlm.nih.gov/42591029
- Dignass A, Farrag K, Stein J. Limitations of serum ferritin in diagnosing iron deficiency in inflammatory conditions. Int J Chronic Dis. 2018;2018:9394060. DOI: 10.1155/2018/9394060. pubmed.ncbi.nlm.nih.gov/29744352
- Cokluk E, Akbay H, Alp HH. Biological Variation of Iron, Transferrin, Ferritin, Folate, Vitamin B12 and 25-OH Vitamin D in Healthy Individuals. Clin Lab. 2021;67(9). DOI: 10.7754/Clin.Lab.2021.210102. pubmed.ncbi.nlm.nih.gov/34542961
- Mansour D, Hofmann A, Gemzell-Danielsson K. A review of clinical guidelines on the management of iron deficiency and iron-deficiency anemia in women with heavy menstrual bleeding. Adv Ther. 2021;38(1):201–225. DOI: 10.1007/s12325-020-01564-y. pubmed.ncbi.nlm.nih.gov/33247314
- Fraser IS, Mansour D, Breymann C, Hoffman C, Mezzacasa A, Petraglia F. Prevalence of heavy menstrual bleeding and experiences of affected women in a European patient survey. Int J Gynaecol Obstet. 2015;128(3):196–200. DOI: 10.1016/j.ijgo.2014.09.027. pubmed.ncbi.nlm.nih.gov/25627706
- Söderman L, et al. Exploring the effect of menstrual loss and dietary habits on iron deficiency in teenagers: A cross-sectional study. PLoS One. 2025;20(12):e0336688. DOI: 10.1371/journal.pone.0336688. pubmed.ncbi.nlm.nih.gov/41335582
- Ebrahim M, Vadive PD, Dutton T, Anyasodor AE, Osuagwu UL, Bailey J. Retrospective audit compares screening and treatment of pregnancy-related anaemia in regional New South Wales with Australian guidelines. BMC Pregnancy Childbirth. 2024;24(1):457. DOI: 10.1186/s12884-024-06634-5. pubmed.ncbi.nlm.nih.gov/38961376
- Auerbach M, Adamson JW. How we diagnose and treat iron deficiency anemia. Am J Hematol. 2016;91(1):31-38. DOI: 10.1002/ajh.24201. pubmed.ncbi.nlm.nih.gov/26408108
- Rohner F, Namaste SM, Larson LM, Addo OY, Mei Z, Suchdev PS, et al. Adjusting soluble transferrin receptor concentrations for inflammation: Biomarkers Reflecting Inflammation and Nutritional Determinants of Anemia (BRINDA) project. Am J Clin Nutr. 2017;106(Suppl 1):372S-382S. DOI: 10.3945/ajcn.116.142232. pubmed.ncbi.nlm.nih.gov/28615256
Guidance and regulatory sources cited in text: Lacher DA, Hughes JP, Carroll MD, Biological variation of laboratory analytes based on the 1999-2002 National Health and Nutrition Examination Survey, National Health Statistics Reports no. 21, 2010, PMID 20540274, for within-person variation in ferritin (17.9% in men, 28.8% in women) · Royal College of Pathologists of Australasia, The Use of Iron Studies, Ferritin and Other Tests of Iron Status, Guideline 3/2017, revised December 2020 · Royal College of Pathologists of Australasia, Iron Studies Standardised Reporting Protocol, 2nd edition, November 2021, which reports the 20 to 37 µg/L commutability spread across 11 assay-instrument configurations and recommends 30 µg/L as the lower reference limit. Australian Red Cross Lifeblood, donation volume for a whole blood donation. RCPA material is quoted briefly and attributed for commentary; its tables and appendices are not reproduced.
Questions and comments